Picture of Kainos Laboratories logo

4556 Kainos Laboratories Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapSuper Stock

Annual cashflow statement for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line613767845930827
Depreciation
Non-Cash Items47.112.410.91.5316.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-211-325-453-620-242
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities591604545431705
Capital Expenditures-73.2-141-7.7-75.7-76.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-44-0.017-2.632.885.63
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-117-141-10.3-72.8-71.3
Financing Cash Flow Items-0.001-0.001-0.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-195-31.3-191-204-411
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash280433343154222